BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31344179)

  • 1. [Recurrence of goodpasture syndrome with negative antiglomerular basement antibodies. Report of one case].
    Tagle R; Arancibia T; Fischman A; Vázquez S; Chahuán J; Méndez GP; Huidobro E JP
    Rev Med Chil; 2019 Mar; 147(3):390-394. PubMed ID: 31344179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report.
    Thibaud V; Rioux-Leclercq N; Vigneau C; Morice S
    BMC Nephrol; 2019 Jan; 20(1):6. PubMed ID: 30621605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glomerular basement membrane antibody disease treated with rituximab: A case-based review.
    Syeda UA; Singer NG; Magrey M
    Semin Arthritis Rheum; 2013 Jun; 42(6):567-72. PubMed ID: 23352254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal vasculitis in antiglomerular basement antibody-positive Goodpasture disease.
    Banks RA; Unsworth KJ; Uff JS
    Nephrol Dial Transplant; 1996 Feb; 11(2):360-2. PubMed ID: 8671795
    [No Abstract]   [Full Text] [Related]  

  • 5. Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature.
    Klasa RJ; Abboud RT; Ballon HS; Grossman L
    Am J Med; 1988 Apr; 84(4):751-5. PubMed ID: 3041810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis.
    L'Imperio V; Ajello E; Pieruzzi F; Nebuloni M; Tosoni A; Ferrario F; Pagni F
    J Nephrol; 2017 Aug; 30(4):503-509. PubMed ID: 28382508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease.
    Liang D; Liang S; Xu F; Zhang M; Li X; Tu Y; Liu Z; Zeng C
    J Clin Pathol; 2019 Jan; 72(1):31-37. PubMed ID: 30315136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-glomerular basement membrane antibodies.
    Silvariño R; Noboa O; Cervera R
    Isr Med Assoc J; 2014 Nov; 16(11):727-32. PubMed ID: 25558706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiglomerular basement membrane (anti-GBM) disease with clinical and histological features that bridge the typical to atypical spectrum.
    Fouhy F; Mayer N; Burke L; O'Shaughnessy M
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34257112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclosporin in Goodpasture's syndrome.
    Quérin S; Schürch W; Beaulieu R
    Nephron; 1992; 60(3):355-9. PubMed ID: 1565189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful rituximab treatment of recurrent glomerulonephritis associated with antibodies against the glomerular basement membrane].
    Chittka D; Lennartz L; Jung B; Banas B; Bergler T
    Internist (Berl); 2020 Apr; 61(4):416-423. PubMed ID: 32179970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Goodpasture disease].
    Fomegné G; Dratwa M; Wens R; Mesquita M; Van der Straaten M; Vanden Haute K; Fosso C
    Rev Med Brux; 2006; 27(3):162-6. PubMed ID: 16894954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen.
    Borza DB; Chedid MF; Colon S; Lager DJ; Leung N; Fervenza FC
    Am J Kidney Dis; 2005 Feb; 45(2):397-406. PubMed ID: 15685519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerulonephritis associated with antibody to glomerular basement membrane.
    Sissons JG; Evans DJ; Peters DK; Eisinger AJ; Boulton-Jones JM; Simpson IJ; Macanovic M
    Br Med J; 1974 Oct; 4(5935):11-4. PubMed ID: 4609543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
    Zhao M; Ding J; Liu Y; Zou W; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Goodpasture's syndrome with immunosuppression and plasmapheresis.
    Finch RA; Rutsky EA; McGowan E; Wilson CB
    South Med J; 1979 Oct; 72(10):1288-90. PubMed ID: 482987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goodpasture disease as a consequence of melioidosis.
    Mackintosh D; Mantha M; Oliver K
    Intern Med J; 2016 Dec; 46(12):1446-1449. PubMed ID: 27981771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report.
    Winkler A; Zitt E; Sprenger-Mähr H; Soleiman A; Cejna M; Lhotta K
    BMC Nephrol; 2021 Feb; 22(1):75. PubMed ID: 33639869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiglomerular basement membrane antibody-mediated glomerulonephritis after intranasal cocaine use.
    Peces R; Navascués RA; Baltar J; Seco M; Alvarez J
    Nephron; 1999; 81(4):434-8. PubMed ID: 10095180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.